Plunkett Research Online: Inozyme Pharma Inc

INOZYME PHARMA INC (INZY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 .....


INOZYME PHARMA INC

Ticker: INZY
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 857 330-4340
Fax:
Address: 321 Summer Street
Boston, MA 2210 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Douglas TrecoCEO/Chairman of the Board/Director
Sanjay SubramanianCFO/Chief Accounting Officer/Secretary
See More
Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture